Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with ...

In April 2026, 10x Genomics launched Atera, an in situ spatial biology platform unveiled at AACR that offers ...

Strategic Buy Lights Up This Biotech Stock: Time to Invest? 10x Genomics (NASDAQ:TXG) reported a first-quarter revenue ...

10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver whole-transcriptome analysis with single-cell sensitivity at scale. Unveiled at the ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience today announced it has commenced commercial operations with the launch of Curio Seeker, the world’s first high-resolution, whole-transcriptome ...

SAN DIEGO--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual ...

Same-slide multiomics will empower oncology researchers to simultaneously analyze the whole transcriptome (~19,000 targets) and immuno-oncology related proteins (up to 76 proteins) within the same ...

Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome ...

The wait is over for the genomics community to learn 10x Genomics’ highly anticipated news. On Saturday night, at the Hard Rock Café Hotel in San Diego—across the street from the American Association ...

CHICAGO--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American ...